Tag: immunotherapies
Bispecific Antibody Evolution for Cancer Therapy: Advances from Merus, Adimab, Regeneron,...
The concept of using bispecific antibodies for tumor therapy has been developed more than 30 years ago with many initial struggles. However, new developments...
Avacta and OncoSec Develop Innovative Gene Delivery of Therapeutic Affimers
Avacta Group, the developer of Affimer® biotherapeutics and reagents, and OncoSec Medical, a company developing intratumoral cancer immunotherapies, have entered into a research collaboration...
Collaboration to Explore the Safety and Efficacy of Combining Rova-T +...
A new Phase I/II clinical program in which Bristol-Myers Squibb collaborates with AbbVie will evaluate the safety, tolerability and efficacy of the investigational biomarker-specific...
